Search research articles
Contact Us
Filters
Showing results (31-40 of 118) with videos related to
Page
of 12
Sort By:
Blood
|
June 9, 2005
Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice
Sigal Tavor, Isabelle Petit, Svetlana Porozov, et al.
Leukemia & Lymphoma
|
January 18, 2014
Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?
Meirav Kedmi, Irit Avivi, Elena Ribakovsky, et al.
Blood Cells, Molecules & Diseases
|
April 3, 2017
Thrombin generation as a predictor of thromboembolic events in multiple myeloma patients
Merav Leiba, Sarah Malkiel, Ivan Budnik, et al.
Ejhaem
|
July 18, 2022
First-line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes
Abraham Avigdor, Fabrizio Trinchese, Francois Gavini, et al.
Experimental Hematology
|
September 14, 2011
CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice
Shoham Shivtiel, Kfir Lapid, Vyacheslav Kalchenko, et al.
Plos One
|
May 1, 2023
Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders
Hila Magen, Abraham Avigdor, Lee Nevo, et al.
Oncotarget
|
September 11, 2016
The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo
Gabriela Rozic, Lena Paukov, Jana Jakubikova, et al.
Acta Haematologica
|
November 21, 2015
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan
Meirav Kedmi, Arie Apel, Tima Davidson, et al.
The Israel Medical Association Journal : IMAJ
|
May 20, 2014
Outcome differences in patients with precursor B cell acute lymphocytic leukemia over time: a retrospective analysis
Arie Apel, Meirav Kedmi, Etai Levi, et al.
Harefuah
|
April 15, 2024
[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE]
Uri Greenbaum, Dana Yehudai-Ofir, Ofrat Beyar Katz, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 118) with videos related to
Sort By:
Page
of 12
Blood
|
June 9, 2005
Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice
Sigal Tavor, Isabelle Petit, Svetlana Porozov, et al.
Leukemia & Lymphoma
|
January 18, 2014
Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?
Meirav Kedmi, Irit Avivi, Elena Ribakovsky, et al.
Blood Cells, Molecules & Diseases
|
April 3, 2017
Thrombin generation as a predictor of thromboembolic events in multiple myeloma patients
Merav Leiba, Sarah Malkiel, Ivan Budnik, et al.
Ejhaem
|
July 18, 2022
First-line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes
Abraham Avigdor, Fabrizio Trinchese, Francois Gavini, et al.
Experimental Hematology
|
September 14, 2011
CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice
Shoham Shivtiel, Kfir Lapid, Vyacheslav Kalchenko, et al.
Plos One
|
May 1, 2023
Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders
Hila Magen, Abraham Avigdor, Lee Nevo, et al.
Oncotarget
|
September 11, 2016
The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo
Gabriela Rozic, Lena Paukov, Jana Jakubikova, et al.
Acta Haematologica
|
November 21, 2015
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan
Meirav Kedmi, Arie Apel, Tima Davidson, et al.
The Israel Medical Association Journal : IMAJ
|
May 20, 2014
Outcome differences in patients with precursor B cell acute lymphocytic leukemia over time: a retrospective analysis
Arie Apel, Meirav Kedmi, Etai Levi, et al.
Harefuah
|
April 15, 2024
[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE]
Uri Greenbaum, Dana Yehudai-Ofir, Ofrat Beyar Katz, et al.
Page
of 12